About: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

retracted scholarly article by Lei Liu published in 2020

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) im März 2020 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2020 (uk) retracted scholarly article by Lei Liu published in 2020 (en)
publication date	wds:Q88486721-E8FCFFE7-0D56-42B6-A2B7-4D9DE3EF6717
publication date	2020-03-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q88486721-32F90470-FC2D-4435-8B2C-6B8C08165413 wds:Q88486721-3FEEEB67-CBDF-4D16-929B-27E10A7BD4B8 wds:Q88486721-53D24EDB-65A4-43BF-B601-C5F9C421E4C7 wds:Q88486721-5CE33154-98D1-4DED-B83B-1B5F870B9A6B wds:Q88486721-6526D91B-B367-4553-8BF1-0662D47BEC0B wds:Q88486721-774F51A8-0345-4439-8C38-424D812AD7BD wds:Q88486721-8212FC13-4DFF-45CB-8EEC-4596091DEA6A wds:Q88486721-8345FF70-390D-44D8-AC37-3FF14E93DDFF wds:Q88486721-A33AAA9D-E8AF-4EC6-9CE8-6090A40A4FB6 wds:Q88486721-A36BA6F5-EBEE-47D5-BD17-9C1DAAC1C29F wds:Q88486721-A7307E52-8B55-4A86-88A7-D1C64C0EA4E5 wds:Q88486721-DA74CFD4-C2EC-427B-9B18-667BF3CF3B8A wds:Q88486721-E1318922-8C4C-4DA6-80E4-94D7DE1A9FC3 wds:Q88486721-F00C55A4-7B0E-4E14-97F8-C5377A5626E1
cites work	Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea Favipiravir (T-705), a novel viral RNA polymerase inhibitor Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model Ebola virus dynamics in mice treated with favipiravir Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Favipiravir for children with Ebola MERS-CoV: Understanding the Latest Human Coronavirus Threat. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Computed tomography findings from patients with ARDS due to Influenza A (H1N1) virus-associated pneumonia Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
author name string	wds:Q88486721-1265A2E9-50ED-4670-8717-787B287623DB wds:Q88486721-3610EBF5-B35F-49A4-B75A-3530A0A53714 wds:Q88486721-3876860B-5287-4747-B0DE-9CE9839EDE0B wds:Q88486721-4AF5B763-854F-48E8-864E-243DE9653B46 wds:Q88486721-4DE9D38A-7DCC-45BD-ADC1-3038BCDD4967 wds:Q88486721-4FE98B4A-7ADF-4D04-9DF2-2DD1F30117EC wds:Q88486721-54CAA369-517F-4584-B828-026424CD5ACB wds:Q88486721-60669E15-C9CB-451E-824D-9194A0AB1076 wds:Q88486721-622F2ED4-6B1C-4E89-9A2C-C8970F78756D wds:Q88486721-7668794B-BC0F-4581-B900-21F0A07FF94D wds:Q88486721-78C4C9F1-7A23-477F-9D4B-32CD5AE18ED4 wds:Q88486721-82A756D0-92C1-479C-B202-94AFDD73D07A wds:Q88486721-84AE2C95-8E2A-4FB0-B937-4641F7DA7109 wds:Q88486721-85E2266E-0E25-4730-BAD8-016E89F7A6A5 wds:Q88486721-8D13F21A-C3B2-4551-AE3A-7791741EEB96 wds:Q88486721-98291CEF-4B75-4717-BFA6-83E86FFE02B9 wds:Q88486721-99C6C546-38EF-475F-9001-194798FCDE7F wds:Q88486721-C132F8C5-8193-41A3-9475-B4FAB010A45A wds:Q88486721-C1E96A17-753E-493B-B752-788533DD2FBC wds:Q88486721-CEC3BE6B-CEED-4B46-B0C4-1DF02E522D38 wds:Q88486721-D8697FCF-C463-4BE2-8CF1-3D6C15D83D5C wds:Q88486721-DA2732CA-9929-448D-B799-A666E100D3A3 wds:Q88486721-E0FA732F-7A2F-4050-9321-81ED21813FA2 wds:Q88486721-F2E8D10E-DFF2-4DFF-B14A-26AC4BE4F7E2 wds:Q88486721-FB115197-5AFA-45F1-8B80-8B118EA2022B wds:Q88486721-FF92C4CD-5B80-454B-8426-3DE24B2B7DC3
author name string	Li Chen Lei Liu Zheng Zhang Jing Zhang Jun Chen Yang Yang Dan Shu Yingxia Liu Wu Zhong Xiaohe Li Minghui Yang Ling Peng Shuyan Chen Fuxiang Wang Shurong Zhang Jiaye Liu Ruiyuan Cao Qingxian Cai Dongjing Liu Deliang Huang Zhaoqin Wang Chenguang Shen Xuejiao Liao Junxia Xia Qiue Cai Yuanbo Gu
rdfs:label	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (en) Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (nl)
skos:prefLabel	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (en) Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (nl)
name	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (en) Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (nl)
author	wds:Q88486721-89982BF1-4033-4C9E-97AC-0E5FF9D4F06C
author	Lei Liu
title	wds:Q88486721-52560E04-B0BA-444D-A127-D2DBE9CCB245
title	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (en)
instance of	wds:Q88486721-AF0E70F9-7796-4DAF-A12F-411BAFA84386

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software